Key facts
- It has raised $4.3M; the latest was Accelerator/Incubator ($70K) in Sep 2025.
- Notable investors include Creative Destruction Lab, US National Science Foundation, SOSV, IndieBio, Hub71 — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Lypid
- ·The full record, as it builds
Funding rounds
No funding rounds for Lypid are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lypid
Producer of alternative fats intended to use animal-free items that will reduce carbon-intensive dependency on animals. The company's product is made using a novel formulation and the microencapsulation method to mimic the texture, mouthfeel, transfer of flavor, and cooking behavior of animal products, enabling consumers to have a healthy alternative with minimal artificial additives, minimal hydrogenation, and less trans fats.
- Sector
- Consumer Products and Services (B2C)
- HQ
- San Francisco, CA, United States
- Founded
- 2020
- Employees
- 14
- Website
- lypid.co/
- Ownership
- Privately Held (backing)
Lypid doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lypid shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lypid in its N-PORT filings yet. We sweep new filings monthly.